Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Telman Deborah H
Apr 26 16:37 ET
Gilead Sciences | 8-K: Gilead Sciences Announces First Quarter 2024 Financial Results
Apr 25 16:09 ET
Gilead Sciences | 3: Initial statement of beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Apr 19 16:36 ET
Gilead Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(13.9%)
Apr 19 16:36 ET
Gilead Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(19.9%)
Apr 5 16:36 ET
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Apr 3 18:54 ET
Gilead Sciences | 3: Initial statement of beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Apr 3 18:54 ET
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Parsey Merdad
Apr 2 18:41 ET
Gilead Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 1 17:06 ET
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Director Lofton Kevin E
Mar 29 17:23 ET
Gilead Sciences | ARS: Annual Report to Security Holders
Mar 28 22:31 ET
Gilead Sciences | DEF 14A: Definitive information statements
Mar 28 16:16 ET
Gilead Sciences | DEFA14A: Others
Mar 28 16:11 ET
Gilead Sciences | 8-K: Gilead Sciences Announces Completion of Acquisition of CymaBay Therapeutics and Enters into an Agreement and Plan of Merger with Wholly-Owned Subsidiary Pacific Merger Sub
Mar 22 09:22 ET
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Mar 22 07:51 ET
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Mar 20 16:19 ET
Gilead Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 18 16:11 ET
Gilead Sciences | SC TO-T/A: Third party tender offer statement (Amendment)
Mar 15 16:18 ET
Gilead Sciences | 8-K: Kevin E. Lofton Will Retire from the Board
Mar 14 16:14 ET
Gilead Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Telman Deborah H
Mar 12 16:24 ET
No Data
No Data